Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Frontiers in pharmacology
Date
2021-01-01
Source
PubMed
DOI
10.3389/fphar.2021.788155
PubMed
35431912
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:48:05 UTC
Metadata last checked
2026-08-09 08:28:20 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Clinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability2026-10-19Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network2026-10-14Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders2026-09-02The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis2026-08-01Retreat from racism: A psychedelic group experience for racial stress and trauma2026-07-30Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression2026-04-09Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice2026-03-22The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?2026-03-01A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations2026-02-28“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy2025-08-25Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics?2025-08-20Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?2025-01-21The Epidemiology of Psychedelic Use Among United States Military Veterans2024-09-12Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports2024-07-17Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)2024-07-12

Related papers

No close related records were found yet.